85622 Feldkirchen, de
+49 (89) 459914-200
PULSION: Preliminary figures for the financial year 2007
EBIT rises to EUR 4.1 million (+21%) in line with forecast / Sales revenue of EUR 28.3 million (+16%) / Capital expenditure at high level / Liquid assets increased once again
Operating profit (EBIT) improved by 21% to EUR 4.1 million (2006: EUR 3.4 million) in line with forecast. The gross margin fell by 2 percentage points from 75% to 73%, primarily as a result of the changed sales mix, lower margins on monitor sales and the pronounced increase of sales revenue generated in the USA where lower margins have so far been achieved.
Earnings before tax (EBT) climbed from EUR 3.3 million in 2006 to EUR 4.0 million in 2007. At EUR 3.9 million, capital expenditure remained at a high level (2006: EUR 2.9 million). Liquid assets (including available-for-sale financial assets) nevertheless increased in 2007 from EUR 5.2 million to EUR 7.0 million.
"We have invested large amounts of time and money in our strategy for the future. Most of the expenditure was on product development, streamlining production and also on new sales and marketing strategies. Although we are not entirely satisfied with the16 percent sales revenue increase to Euro 28.3 million, we nevertheless succeeded in increasing EBIT by 21%", says Bradley Gould, CEO of PULSION Medical Systems AG.
The complete and audited consolidated financial statements will be made public on March 20, 2008.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an firstname.lastname@example.org.